mAbs are designed for people who● Have tested positive for COVID-19, and● Have mild to moderate symptoms of the disease for 10 days or less, and● Are at high risk of becoming seriously ill. ● Or high risk and exposed to someone who recently tested positive and not fully vaccinated.